about
64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissuesDevelopment and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy.Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumorsGallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression.Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors.Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha.(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects.Visualization of biodistribution of Zn complex with antidiabetic activity using semiconductor Compton camera GREIEvaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons.Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model.Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study.Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter.Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.Water-tunable solvatochromic and nanoaggregate fluorescence: dual colour visualisation and quantification of trace water in tetrahydrofuran.In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects.Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT.Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.Change of central cholinergic receptors following lesions of nucleus basalis magnocellularis in rats: search for an imaging index suitable for the early detection of Alzheimer's disease.Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains.Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.Reversible near-infrared/blue mechanofluorochromism of aminobenzopyranoxanthene.Red blood cell coagulation induced by low-temperature plasma treatment.GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging.Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo.Investigation of Biodistribution and Speciation Changes of Orally Administered Dual Radiolabeled Complex, Bis(5-chloro-7-[131I]iodo-8-quinolinolato)[65Zn]zinc.Clinical efficacy of dual-phase scanning using (68)Ga-DOTATOC-PET/CT in the detection of neuroendocrine tumours.Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.Enhanced stability of Cu(2+)-ATCUN complexes under physiologically relevant conditions by insertion of structurally bulky and hydrophobic amino acid residues into the ATCUN motif.Development of radiolabeled compounds for molecular imaging and imaging-based therapy.Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliationEvaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistryEvaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's DiseaseSynthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyl-technetium-labeled A-85380: An imaging probe for single-photon emission computed tomography investigation of nicotinic acetylcholine receptors in the brain
P50
Q34443711-BDAEF957-5235-47CD-840F-6E0B5B6616E5Q35063912-6F236F11-970E-4B3F-92D1-18A69301578EQ36322884-1831F14C-3529-4093-9EAD-D1379F26CFD3Q38973014-DC89C00B-603B-49AC-85AA-87B41365F9E6Q39019681-62A3EF4F-3FFC-4ECD-9D8B-E1683FE51421Q39149491-DC30A552-1D67-44CF-AE92-24956BB4BBD7Q39709413-3A93AF05-87EA-4C2F-B362-19EAA43EAFD0Q39736843-2D0E87AD-96E7-4F5E-9356-8F1DF128C8FDQ39884251-19917C47-064E-4E84-9E27-DA53407646CAQ41683371-6031EDFC-128A-4E7A-814A-9F7C46C818AEQ44069607-BF4E2C0A-10EC-44C4-B318-DB8CCABA3AB5Q45053629-17835B4B-ED8D-4A91-8D77-CE9A698187B9Q46011398-717C55A5-7D53-43DD-9758-8C729FB3C4AAQ46121965-59FC75EA-F576-4436-90D4-4E7BAB54BD1CQ46723795-BA8B8737-4659-42F5-B1A3-97FEEABC944BQ46757733-8691A23C-E551-46B7-BD94-8BE53BB6CB73Q46941234-376D6DBF-D2B4-4397-A658-865458E93486Q46945327-1C4EB853-EBC7-4056-ADF3-535AB4AEDCCFQ46980051-82A189D6-6284-4559-BB7A-5A761375E63DQ47215987-7A795D9E-E19B-4735-AF94-352030704EF1Q48161765-82F92259-A3AD-4D3A-947E-22A600093925Q48184077-7110CEF0-E9C0-416B-817C-2207342BDF8CQ48237589-13F63EDC-6284-4D2D-9F81-538F99AC5944Q48476095-0C9A1D97-D1D5-4E2B-B6E2-2D9EA8A59695Q48612859-3F3C96C6-7C28-4FDD-AA7F-BB3FC30D1682Q48642074-C15B60F0-9F37-4553-8FED-1C5EF7035BEFQ48695243-286BEF10-A750-454F-89B6-BFD69ACB2A1FQ50214166-E2482426-65B8-45DE-B1AA-4FFDA8D1A1E4Q50246390-4F291623-B5ED-471E-90B7-1F0599EF4AEBQ50583713-4BAA3DCB-C9EA-465D-B330-18F01247A8E9Q51761444-540C1B17-5925-42A3-B58B-95EACA51BE4EQ52688978-259A2097-9EB3-4B1D-8C33-B66202FDAE8DQ52982809-F4125D54-617E-436F-A598-375A8F566307Q53051729-9AAC58BB-4ACA-4865-9A60-977BC6EABB53Q54630025-7BF8CA40-C362-47AE-B0C4-4FB04DA61353Q55437946-A9B6A368-A182-4B1C-A952-62FCC4990E28Q83832072-92DF0401-B1D2-49E3-8ECC-83C239018398Q84716532-9A535F50-5923-4D9A-A355-A05F6CACC90FQ90482443-BC0B3768-CAE5-4CE8-8819-95E05FAFBB53Q91705834-B5147772-C718-4601-9664-7ABFA8535D69
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Masashi Ueda
@ast
Masashi Ueda
@en
Masashi Ueda
@es
Masashi Ueda
@nl
Masashi Ueda
@sl
type
label
Masashi Ueda
@ast
Masashi Ueda
@en
Masashi Ueda
@es
Masashi Ueda
@nl
Masashi Ueda
@sl
prefLabel
Masashi Ueda
@ast
Masashi Ueda
@en
Masashi Ueda
@es
Masashi Ueda
@nl
Masashi Ueda
@sl
P1053
K-4096-2013
P106
P21
P31
P3829
P496
0000-0001-7027-1568